<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00469482</url>
  </required_header>
  <id_info>
    <org_study_id>061218</org_study_id>
    <secondary_id>SOMNUS</secondary_id>
    <nct_id>NCT00469482</nct_id>
  </id_info>
  <brief_title>The SOMNUS Study: Sedative Optimization Via Monitoring Neurological Status</brief_title>
  <acronym>SOMNUS</acronym>
  <official_title>A Randomized Control Trial Using the BIS Monitor to Avoid Over Sedation and Prolonged Neuropsychological Deficits in Mechanically Ventilated ICU Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic - MITG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A combined strategy of Richmond Agitation and Sedation Scale (RASS) clinical targeting plus
      bispectral index (BIS) guided sedation in mechanically ventilated, critically ill patients
      will decrease time on mechanical ventilation, decrease the duration of intensive care unit
      (ICU) delirium and coma, and will improve subacute neurocognitive function when compared to
      sedation guided by RASS targeting alone.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sedatives and analgesics are used to maintain comfort in almost all mechanically ventilated
      patients. Unfortunately, these medications also have many deleterious effects. Sedatives
      increase time on mechanical ventilation, have adverse hemodynamic effects, disturb sleep
      architecture, and have been determined to be an independent risk factor for ICU delirium.
      Delirium is an independent determinant of longer hospital stay, higher costs, and higher
      mortality, and the presence of delirium is highly predictive of long-term neurocognitive
      deficits. In consideration of these facts, better methods are needed to guide sedation, avoid
      oversedation, and possibly reduce delirium.

      Current guidelines recommend titration of sedation to a goal level based on bedside
      evaluation using a validated assessment tool, e.g. the Richmond Agitation and Sedation Scale.
      These assessment tools, however, are underused and many ICU patients are oversedated with
      well described consequences. A practical method by which to determine where a patient lies
      may prove beneficial in optimizing our delivery of sedatives and improving patient outcomes.

      While conventional EEG monitoring is not practical in the ICU, bispectral index (BIS)
      monitoring may be easily used in this clinical setting. BIS monitoring may provide a means to
      assess sedation level in unresponsive or paralyzed ICU patients and to decrease the total
      amount of sedatives/analgesics administered. Additional benefits of a combined clinical
      sedation scale and BIS-monitoring approach could include a decreased incidence and/or
      duration of delirium as well as a decreased incidence and severity of ICU-associated
      prolonged neurocognitive deficits.

      The specific aims of this study are as follows:

      Aim 1: To determine if sedative and analgesic medication delivery guided by clinical sedation
      scales and BIS monitor parameters of over-sedation will decrease time on mechanical
      ventilation.

      Aim 2: To determine if sedative and analgesic medication delivery guided by clinical sedation
      scales and BIS monitor parameters of over-sedation will decrease the duration of delirium and
      coma when compared to the use of clinical sedations scales alone.

      Aim 3: To determine if sedative and analgesic medication delivery guided by clinical sedation
      scales and BIS monitor parameters of over-sedation will decrease the incidence and severity
      of subacute cognitive impairment when compared to the use of clinical sedation scales alone.

      Aim 4: To characterize polysomnography findings in critically ill patients at various BIS
      levels.

      Aim 5: To determine if poor sleep quality is a factor in post critical illness neurocognitive
      dysfunction.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2007</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">October 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of ventilator free hours and days</measure>
    <time_frame>while in ICU, appoximately 3-7 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of delirium and coma free days</measure>
    <time_frame>while in ICU, appoximately 3-7 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of subacute cognitive dysfunction using RBANS- Repeatable Battery for the Assessment of Neuropsychological Status,</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of subacute cognitive dysfunction using TRAILS A&amp;B</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of subacute cognitive dysfunction using SF-36 - Short Form Health Survey</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of subacute cognitive dysfunction using MMSE - Mini Mental State Examination</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of subacute cognitive dysfunction using IADLs - instrumental activities of daily living</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of subacute cognitive dysfunction using AD8- ADL - activities of daily living</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of subacute cognitive dysfunction using APACHE II - Acute Physiologic and Chronic Health Evaluation II score</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU length of stay</measure>
    <time_frame>while in ICU, appoximately 3-7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital length of stay</measure>
    <time_frame>while in hospital, usually 5-10 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Six month mortality</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biomarkers for neurological injury and inflammation, Neuron-Specific Enolase (NSE)</measure>
    <time_frame>Baseline, Day 3 and at Ventilator removal (appoximately day 3-7)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biomarkers for neurological injury and inflammation, S100</measure>
    <time_frame>Baseline, Day 3 and at Ventilator removal (appoximately day 3-7)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biomarkers for neurological injury and inflammation, IL-6</measure>
    <time_frame>Baseline, Day 3 and at Ventilator removal (appoximately day 3-7)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biomarkers for neurological injury and inflammation, C Reactive Protein (CRP)</measure>
    <time_frame>Baseline, Day 3 and at Ventilator removal (appoximately day 3-7)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sleep quality</measure>
    <time_frame>within 24 hours of enrollment through day 3-7</time_frame>
    <description>measured with continuous polysomnography</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Delirium</condition>
  <condition>Cognitive Impairment</condition>
  <condition>Critically Ill</condition>
  <arm_group>
    <arm_group_label>Sedation, RASS Targeted</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient sedation utilizing standard of care methods (RASS Targeted)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sedation,RASS Targeted plus BIS Monitoring</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Providing patient sedation utilizing standard of care methods (RASS) plus BIS monitoring.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sedation,RASS Targeted plus BIS Monitoring</intervention_name>
    <description>Providing patient sedation utilizing standard of care methods (RASS) plus BIS monitoring</description>
    <arm_group_label>Sedation,RASS Targeted plus BIS Monitoring</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sedation, RASS Targeted</intervention_name>
    <description>Patient sedation utilizing standard of care methods (RASS targeted)</description>
    <arm_group_label>Sedation, RASS Targeted</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female adult patients admitted to the ICU for critical illnesses requiring
             mechanical ventilation with expectation of being mechanically ventilated for greater
             than 24 hours. Subjects must have an actual or a target RASS of -3 or deeper with 48
             hours of initiation of mechanical ventilation.

        Exclusion Criteria:

          -  Subjects who are less than 18 years old.

          -  Inability to obtain informed consent from the patient or his/her surrogate.

          -  Subjects admitted with alcohol or drug overdoses, suicide attempts, or
             alcohol/delirium with tremors.

          -  Subjects with documented moderate to severe dementia.

          -  Subjects with anoxic brain injuries, strokes, neurotrauma, or neuromuscular disorders
             such as myasthenia gravis or Guillain Barre syndrome.

          -  Subjects whose family and/or physician have not committed to aggressive support for 72
             hours or who are likely to withdraw within 72 hours.

          -  Subjects who are moribund or are not expected to survive hospital discharge due to
             preexisting uncorrectable medical condition.

          -  Subjects who have either Child-Pugh Class B or C cirrhosis.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wes Ely, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt Universtiy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.ICUdelirium.org</url>
    <description>This is an educational website about ICU delirium.</description>
  </link>
  <reference>
    <citation>Marcantonio ER, Juarez G, Goldman L, Mangione CM, Ludwig LE, Lind L, Katz N, Cook EF, Orav EJ, Lee TH. The relationship of postoperative delirium with psychoactive medications. JAMA. 1994 Nov 16;272(19):1518-22.</citation>
    <PMID>7966844</PMID>
  </reference>
  <reference>
    <citation>Pandharipande P, Shintani A, Peterson J, Pun BT, Wilkinson GR, Dittus RS, Bernard GR, Ely EW. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology. 2006 Jan;104(1):21-6.</citation>
    <PMID>16394685</PMID>
  </reference>
  <reference>
    <citation>Inouye SK, Schlesinger MJ, Lydon TJ. Delirium: a symptom of how hospital care is failing older persons and a window to improve quality of hospital care. Am J Med. 1999 May;106(5):565-73. Review.</citation>
    <PMID>10335730</PMID>
  </reference>
  <reference>
    <citation>Dubois MJ, Bergeron N, Dumont M, Dial S, Skrobik Y. Delirium in an intensive care unit: a study of risk factors. Intensive Care Med. 2001 Aug;27(8):1297-304.</citation>
    <PMID>11511942</PMID>
  </reference>
  <reference>
    <citation>Inouye SK, Charpentier PA. Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability. JAMA. 1996 Mar 20;275(11):852-7.</citation>
    <PMID>8596223</PMID>
  </reference>
  <reference>
    <citation>Ely EW, Gautam S, Margolin R, Francis J, May L, Speroff T, Truman B, Dittus R, Bernard R, Inouye SK. The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med. 2001 Dec;27(12):1892-900. Epub 2001 Nov 8.</citation>
    <PMID>11797025</PMID>
  </reference>
  <reference>
    <citation>Ely EW, Shintani A, Truman B, Speroff T, Gordon SM, Harrell FE Jr, Inouye SK, Bernard GR, Dittus RS. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA. 2004 Apr 14;291(14):1753-62.</citation>
    <PMID>15082703</PMID>
  </reference>
  <reference>
    <citation>Milbrandt EB, Deppen S, Harrison PL, Shintani AK, Speroff T, Stiles RA, Truman B, Bernard GR, Dittus RS, Ely EW. Costs associated with delirium in mechanically ventilated patients. Crit Care Med. 2004 Apr;32(4):955-62.</citation>
    <PMID>15071384</PMID>
  </reference>
  <reference>
    <citation>Jackson JC, Gordon SM, Hart RP, Hopkins RO, Ely EW. The association between delirium and cognitive decline: a review of the empirical literature. Neuropsychol Rev. 2004 Jun;14(2):87-98. Review.</citation>
    <PMID>15264710</PMID>
  </reference>
  <reference>
    <citation>Jacobi J, Fraser GL, Coursin DB, Riker RR, Fontaine D, Wittbrodt ET, Chalfin DB, Masica MF, Bjerke HS, Coplin WM, Crippen DW, Fuchs BD, Kelleher RM, Marik PE, Nasraway SA Jr, Murray MJ, Peruzzi WT, Lumb PD; Task Force of the American College of Critical Care Medicine (ACCM) of the Society of Critical Care Medicine (SCCM), American Society of Health-System Pharmacists (ASHP), American College of Chest Physicians. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med. 2002 Jan;30(1):119-41. Erratum in: Crit Care Med 2002 Mar;30(3):726.</citation>
    <PMID>11902253</PMID>
  </reference>
  <reference>
    <citation>Kollef MH, Levy NT, Ahrens TS, Schaiff R, Prentice D, Sherman G. The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. Chest. 1998 Aug;114(2):541-8.</citation>
    <PMID>9726743</PMID>
  </reference>
  <reference>
    <citation>Kress JP, Pohlman AS, O'Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med. 2000 May 18;342(20):1471-7.</citation>
    <PMID>10816184</PMID>
  </reference>
  <reference>
    <citation>Aurell J, Elmqvist D. Sleep in the surgical intensive care unit: continuous polygraphic recording of sleep in nine patients receiving postoperative care. Br Med J (Clin Res Ed). 1985 Apr 6;290(6474):1029-32.</citation>
    <PMID>3921096</PMID>
  </reference>
  <reference>
    <citation>Cooper AB, Thornley KS, Young GB, Slutsky AS, Stewart TE, Hanly PJ. Sleep in critically ill patients requiring mechanical ventilation. Chest. 2000 Mar;117(3):809-18. Erratum in: Chest 2001 Mar;119(3):993.</citation>
    <PMID>10713011</PMID>
  </reference>
  <reference>
    <citation>Sleigh JW, Andrzejowski J, Steyn-Ross A, Steyn-Ross M. The bispectral index: a measure of depth of sleep? Anesth Analg. 1999 Mar;88(3):659-61.</citation>
    <PMID>10072023</PMID>
  </reference>
  <reference>
    <citation>Grocott HP, Newman MF, El-Moalem H, Bainbridge D, Butler A, Laskowitz DT. Apolipoprotein E genotype differentially influences the proinflammatory and anti-inflammatory response to cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2001 Sep;122(3):622-3.</citation>
    <PMID>11547323</PMID>
  </reference>
  <reference>
    <citation>Weigand MA, Volkmann M, Schmidt H, Martin E, Böhrer H, Bardenheuer HJ. Neuron-specific enolase as a marker of fatal outcome in patients with severe sepsis or septic shock. Anesthesiology. 2000 Mar;92(3):905-7.</citation>
    <PMID>10719986</PMID>
  </reference>
  <reference>
    <citation>Hopkins RO, Weaver LK, Pope D, Orme JF, Bigler ED, Larson-LOHR V. Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome. Am J Respir Crit Care Med. 1999 Jul;160(1):50-6.</citation>
    <PMID>10390379</PMID>
  </reference>
  <reference>
    <citation>Norris PR, Dawant BM. Closing the loop in ICU decision support: physiologic event detection, alerts, and documentation. Proc AMIA Symp. 2001:498-502.</citation>
    <PMID>11825238</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 3, 2007</study_first_submitted>
  <study_first_submitted_qc>May 3, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 4, 2007</study_first_posted>
  <last_update_submitted>March 6, 2018</last_update_submitted>
  <last_update_submitted_qc>March 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University Medical Center</investigator_affiliation>
    <investigator_full_name>Wes Ely</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Delirium</keyword>
  <keyword>Cognitive Impairment</keyword>
  <keyword>Sleep</keyword>
  <keyword>Polysomnography</keyword>
  <keyword>Sedation</keyword>
  <keyword>Mechanical Ventilation</keyword>
  <keyword>Critical Illness</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cognitive Dysfunction</mesh_term>
    <mesh_term>Critical Illness</mesh_term>
    <mesh_term>Delirium</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

